Literature DB >> 16912581

Developing and optimizing a decisional instrument using self-reported ancestry for carrier screening in a multi-ethnic society.

Phillis Lakeman1, Lidewij Henneman, Pieter Dirk Bezemer, Martina Cornelia Cornel, Leo Pieter ten Kate.   

Abstract

PURPOSE: To develop a decisional instrument for ancestry-based cystic fibrosis and/or hemoglobinopathies carrier couple screening in The Netherlands.
METHODS: A flowchart (Instrument A) and a questionnaire with maps of geographical areas with originally high cystic fibrosis and hemoglobinopathies carrier frequencies (Instrument B), were developed to support participants in self-assessing their eligibility as a couple for carrier screening for cystic fibrosis and/or hemoglobinopathies. The outcome was compared to the self-reported origin of both partners' ancestors during an in-depth interview. Furthermore, preference for Instrument A or B was determined.
RESULTS: Of the 112 participants, 88% (99/112, 95% CI 82-94%) (Instrument A) and 91% (102/112, 95% CI 86-96%) (Instrument B), respectively, arrived at a decision in accordance with their ancestral origin, and 57% (64/112, 95% CI 48-66%) preferred Instrument B. A false negative proportion of 5.5% suggests that some carriers will exclude themselves from screening. Results might improve with minor changes in the instruments with regard to geographic specification, and availability of translated versions.
CONCLUSION: A decisional instrument to assess ancestry-based eligibility for cystic fibrosis and/or hemoglobinopathies carrier screening, is now available and can with slight adaptations be used in other countries. The instrument also takes into account the possibility of mixed ancestry.

Entities:  

Mesh:

Year:  2006        PMID: 16912581     DOI: 10.1097/01.gim.0000232461.11153.9a

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  8 in total

1.  Attitudes of health care professionals toward carrier screening for cystic fibrosis. A review of the literature.

Authors:  S Janssens; A De Paepe; P Borry
Journal:  J Community Genet       Date:  2012-12-29

2.  Preconceptional ancestry-based carrier couple screening for cystic fibrosis and haemoglobinopathies: what determines the intention to participate or not and actual participation?

Authors:  Phillis Lakeman; Anne Marie Catharina Plass; Lidewij Henneman; Pieter Dirk Bezemer; Martina Cornelia Cornel; Leo Pieter ten Kate
Journal:  Eur J Hum Genet       Date:  2009-02-18       Impact factor: 4.246

3.  Attitudes of general practitioners and midwives towards ethnicity-based haemoglobinopathy-carrier screening.

Authors:  Suze M P J Jans; Ank de Jonge; Lidewij Henneman; Martina C Cornel; Antoinette L M Lagro-Janssen
Journal:  Eur J Hum Genet       Date:  2012-05-02       Impact factor: 4.246

4.  A case study of haemoglobinopathy screening in the Netherlands: witnessing the past, lessons for the future.

Authors:  Suze M P J Jans; Carla G van El; Eddy S Houwaart; Marjan J Westerman; Rien J P A Janssens; Antoinette L M Lagro-Janssen; Anne Marie C Plass; Martina C Cornel
Journal:  Ethn Health       Date:  2011-08-08       Impact factor: 2.772

5.  'A morass of considerations': exploring attitudes towards ethnicity-based haemoglobinopathy-carrier screening in primary care.

Authors:  S M P J Jans; L Henneman; A de Jonge; C G van El; L H van Tuyl; M C Cornel; A L M Lagro-Janssen
Journal:  Fam Pract       Date:  2013-04-29       Impact factor: 2.267

6.  Responsible implementation of expanded carrier screening.

Authors:  Lidewij Henneman; Pascal Borry; Davit Chokoshvili; Martina C Cornel; Carla G van El; Francesca Forzano; Alison Hall; Heidi C Howard; Sandra Janssens; Hülya Kayserili; Phillis Lakeman; Anneke Lucassen; Sylvia A Metcalfe; Lovro Vidmar; Guido de Wert; Wybo J Dondorp; Borut Peterlin
Journal:  Eur J Hum Genet       Date:  2016-03-16       Impact factor: 4.246

7.  Raising awareness of carrier testing for hereditary haemoglobinopathies in high-risk ethnic groups in the Netherlands: a pilot study among the general public and primary care providers.

Authors:  Stephanie S Weinreich; Elly Sm de Lange-de Klerk; Frank Rijmen; Martina C Cornel; Marja de Kinderen; Anne Marie C Plass
Journal:  BMC Public Health       Date:  2009-09-15       Impact factor: 3.295

8.  The attitudes and intention to participate in hemoglobinopathy carrier screening in The Netherlands among individuals from Turkish, Moroccan, and Surinamese descent.

Authors:  Sylvia M van der Pal; Nicole M C van Kesteren; Jacobus P van Wouwe; Paula van Dommelen; Symone B Detmar
Journal:  J Environ Public Health       Date:  2013-11-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.